Literature DB >> 2736107

Neoplasms of the central nervous system in Norway. III. Epidemiological characteristics of intracranial gliomas according to histology.

A Helseth1, S J Mørk.   

Abstract

Data were analysed from 4859 patients with different histological types of intracranial glioma registered by the Norwegian Cancer Registry between 1955 and 1984. Glioblastoma comprised 57.9% of all cases. The second most common primary brain tumour was astrocytoma (19.0%), then mixed glioma (9.2%), oligodendroglioma (7.9%), medulloblastoma (3.1%) and ependymoma (2.9%). A primary brain tumour in a child is approximately twice as likely to be an astrocytoma as a medulloblastoma. The age-specific incidence for glioblastoma increases with age, whereas the incidence of astrocytoma and oligodendroglioma peaks at middle age. Both glioblastoma and astrocytoma showed increased incidence rates over the study period and this was most pronounced in the age-group above 60 years. The prognosis for gliomas varied with age at time of diagnosis, generally being better the younger the patient. For oligodendroglioma patients, survival prospects were independent of age at time of diagnosis. The best prognosis was seen in patients up to 30 years with astrocytoma. Applied in epidemiology, the data indicate that astrocytoma, oligodendroglioma, mixed glioma and ependymoma may be treated as a group which should be separated from both glioblastoma and medulloblastoma.

Entities:  

Mesh:

Year:  1989        PMID: 2736107

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  10 in total

1.  Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas.

Authors:  Sergei I Bannykh; C Claus Stolt; Jung Kim; Arie Perry; Michael Wegner
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

2.  Treatment of malignant gliomas in the elderly.

Authors:  J Y Pierga; K Hoang-Xuan; L Feuvret; J M Simon; P Cornu; F Baillet; J J Mazeron; J Y Delattre
Journal:  J Neurooncol       Date:  1999-06       Impact factor: 4.130

3.  Population-based incidence and survival of central nervous system (CNS) malignancies in Girona (Spain) 1994-2005.

Authors:  Rafael Fuentes-Raspall; Loreto Vilardell; Ferran Perez-Bueno; Carmen Joly; Maria Garcia-Gil; Adelaida Garcia-Velasco; Rafael Marcos-Gragera
Journal:  J Neurooncol       Date:  2010-06-11       Impact factor: 4.130

Review 4.  Environmental risk factors for primary malignant brain tumors: a review.

Authors:  M Wrensch; M L Bondy; J Wiencke; M Yost
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

5.  Third ventricular glioblastoma multiforme: case report.

Authors:  T T Lee; G R Manzano
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

Review 6.  Incidence studies of primary and secondary intracranial tumors: a systematic review of their methodology and results.

Authors:  C E Counsell; R Grant
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

7.  Exophytic malignant brainstem mixed glioma in an adult: a case report.

Authors:  T T Lee; M Galarza; C K Petito; R C Heros
Journal:  J Neurooncol       Date:  1998-04       Impact factor: 4.130

Review 8.  Epidemiology of Glioblastoma Multiforme-Literature Review.

Authors:  Szymon Grochans; Anna Maria Cybulska; Donata Simińska; Jan Korbecki; Klaudyna Kojder; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Cancers (Basel)       Date:  2022-05-13       Impact factor: 6.575

Review 9.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

10.  Incidence of and survival from oligodendroglioma in Denmark, 1943-2002.

Authors:  Malene Schjønning Nielsen; Helle Collatz Christensen; Michael Kosteljanetz; Christoffer Johansen
Journal:  Neuro Oncol       Date:  2008-12-09       Impact factor: 12.300

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.